Recruiting Hypertension Studies in Tucson
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
The purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients with mild to moderate hy...
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
This study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD; Day 1 to Week 12)....
About Hypertension Clinical Trials in Tucson
Hypertension, or high blood pressure, is a common condition that increases the risk of heart disease, stroke, and kidney damage. Often called the "silent killer" because it usually has no symptoms. Management includes lifestyle modifications and medications to lower blood pressure.
There are currently 2 hypertension clinical trials recruiting participants in Tucson, ARIZONA. These studies are seeking a combined 610 participants. Research is being sponsored by Novartis Pharmaceuticals, Tenax Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hypertension Clinical Trials in Tucson — FAQ
Are there hypertension clinical trials in Tucson?
Yes, there are 2 hypertension clinical trials currently recruiting in Tucson, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tucson?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.
Are clinical trials in Tucson free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.
What hypertension treatments are being tested?
The 2 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov